Moataz Shaldam

35PUBLICATIONS
94CO-AUTHORS
Biomolecular modelling and designBiologically active moleculesMedical biotechnology diagnostics (incl. biosensors)Traditional Chinese medicine and treatmentsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Sep 10, 2026
Tailored [1,2,4]triazolo[1,5-a]pyrimidine hybrids as promising anti-inflammatory agents with COX/5-LOX/ROS/IL-6 multifunctional inhibitory activity: design, synthesis, SAR, and in silico study.

|Sep 02, 2026
Design and synthesis of 1,3,4-oxadiazole-tethered N-substituted isatin hybrids as SARS-CoV-2 main protease inhibitors: biological evaluation, kinetic investigation, and in silico studies.

|Aug 27, 2026
Synthesis, Antibacterial Evaluation, and Chemometric Profiling of a Vanilloid-Based Compounds Library Active Against Helicobacter pylori.

|May 28, 2026
Molecular Boomerangs Against Cancer: Design, Synthesis, Biological Evaluation, and In Silico Study of Novel Dual PARP-1/EGFR Inhibitors.

|Mar 30, 2026
Thiazole-Semicarbazone Hybrids as Dual-Stage Inhibitors of Leishmania major Growth: Design, Synthesis, and Mechanistic Insights.

Moataz A Shaldam, Haytham O Tawfik, Abdelrahman I Zain-Alabdeen

|Feb 06, 2026
Design, synthesis, and molecular modeling of novel thiazolopyridine-based inhibitors of enoyl acyl carrier protein reductase (InhA) as anti-Mycobacterium tuberculosis agents.

Ahmed Sabt, Małgorzata Korycka-Machała, Asmaa F Kassem

Pageof 6

Frequent Collaborators

15 joint publications

Haytham Tawfik

13 joint publications

Wagdy M Eldehna

8 joint publications

Claudiu T Supuran

7 joint publications

Hisham A Abbas